Cellular processing of platinum anticancer drugs

@article{Wang2005CellularPO,
  title={Cellular processing of platinum anticancer drugs},
  author={D. Wang and S. Lippard},
  journal={Nature Reviews Drug Discovery},
  year={2005},
  volume={4},
  pages={307-320}
}
  • D. Wang, S. Lippard
  • Published 2005
  • Biology, Medicine
  • Nature Reviews Drug Discovery
    • Cisplatin, carboplatin and oxaliplatin are platinum-based drugs that are widely used in cancer chemotherapy. Platinum–DNA adducts, which are formed following uptake of the drug into the nucleus of cells, activate several cellular processes that mediate the cytotoxicity of these platinum drugs. This review focuses on recently discovered cellular pathways that are activated in response to cisplatin, including those involved in regulating drug uptake, the signalling of DNA damage, cell-cycle… CONTINUE READING
    View on Springer
    ncbi.nlm.nih.gov
    2,642 Citations
    Highly Influential Citations
    84
    Background Citations
    834
    Methods Citations
    21
    Results Citations
    8

    Figures, Tables, and Topics from this paper

    Figures and Tables

    Explore Further: Topics Discussed in This Paper

    2,642 Citations
    Citation Type

    Citation Type

    Inhibition of transcription by platinum antitumor compounds.
    • 393
    • PDF
    Understanding and improving platinum anticancer drugs--phenanthriplatin.
    • 191
    Platinum–DNA Interactions and Subsequent Cellular Processes Controlling Sensitivity to Anticancer Platinum Complexes
    • S. Ahmad
    • Chemistry, Medicine
    • Chemistry & biodiversity
    • 2010
    • 114
    Cisplatin and Related Drugs
    • 15
    Cellular Responses to Cisplatin-Induced DNA Damage
    • 302
    • PDF
    The mechanism of tumour cell death by metal-based anticancer drugs is not only a matter of DNA interactions
    • 47
    The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy.
    • 377
    Action of the anticancer drug cisplatin investigated by molecular simulation
    • Highly Influenced
    • PDF
    Understanding and Improving Platinum Anticancer Drugs
    • 1
    Monofunctional Platinum(II) Anticancer Agents

    References

    SHOWING 1-10 OF 234 REFERENCES
    Recognition of cisplatin adducts by cellular proteins.
    • 308
    Cellular and molecular pharmacology of oxaliplatin.
    • 443
    Current status of the development of trans-platinum antitumor drugs.
    • 102
    Cross-linking of glutathione to DNA by cancer chemotherapeutic platinum coordination complexes.
    • A. Eastman
    • Chemistry, Medicine
    • Chemico-biological interactions
    • 1987
    • 139
    Protein interactions with platinum-DNA adducts: from structure to function.
    • 87
    Mini-review: discovery and development of platinum complexes designed to circumvent cisplatin resistance.
    • 170
    Decreased cisplatin uptake by resistant L1210 leukemia cells.
    • 67
    Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA.
    • 454
    • PDF
    Clinical development of platinum complexes in cancer therapy: an historical perspective and an update.
    • 621
    Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel.
    • 561